Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Morpholine-3-carboxylic acid hydrochloride → 4-((6-(2,4-Dichlorophenyl)-5-(methoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholine-3-carboxylic acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Morpholine-3-carboxylic acid hydrochloride | HCID 45790954 | — |
| 반응물 | Methyl 6-(bromomethyl)-4-(2,4-dichlorophenyl)-2-(thiazol-2-yl)-1,4-dihydropyrimidine-5-carboxylate | HCID 118107550 | — |
| 생성물 | 4-((6-(2,4-Dichlorophenyl)-5-(methoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholine-3-carboxylic acid | HCID 90043654 | 45% |
반응 단계
Methyl 6-(bromomethyl)-4-(2,4-dichlorophenyl)-2-(thiazol-2-yl)-1,4-dihydropyrimidine-5-carboxylate (3.02 g, 6.54 mmol) (The compound was synthesized according to the procedure as described in WO2010069147A) was reacted with morpholine-3-carboxylic acid hydrochloride (1.1 g, 6.54 mmol) according to the procedure as described in Example 3 to give the title compound as a yellow solid (1.5 g, 45%). The compound was characterized by the following spectroscopic data:
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09340538B2 |
| 출처 데이터셋 | uspto-grants-2016_05 |
| ORD ID | ord-c3e3c662120241c2a5b9e784957c4096 |
| 출처 메모 | uspto-grants-2016_05 |